Latest Stories
3 Reasons QRVO is Risky and 1 Stock to Buy Instead
Over the past six months, Qorvo’s shares (currently trading at $82.50) have posted a disappointing 10.2% loss, well below the S&P 500’s 7.2% gain. This may have investors wondering how to approach the situation.
3 Reasons EBAY is Risky and 1 Stock to Buy Instead
Over the past six months, eBay’s shares (currently trading at $87.71) have posted a disappointing 6.4% loss, well below the S&P 500’s 7.2% gain. This may have investors wondering how to approach the situation.
2 Reasons to Avoid MKTX and 1 Stock to Buy Instead
Since August 2025, MarketAxess has been in a holding pattern, posting a small loss of 1.4% while floating around $184.95. The stock also fell short of the S&P 500’s 7.2% gain during that period.
Enova (ENVA): Buy, Sell, or Hold Post Q4 Earnings?
Enova currently trades at $147.65 and has been a dream stock for shareholders. It’s returned 369% since February 2021, blowing past the S&P 500’s 77.9% gain. The company has also beaten the index over the past six months as its stock price is up 23.3% thanks to its solid quarterly results.
3 Reasons CNMD is Risky and 1 Stock to Buy Instead
Over the past six months, CONMED’s shares (currently trading at $45.91) have posted a disappointing 15.7% loss, well below the S&P 500’s 7.2% gain. This was partly due to its softer quarterly results and might have investors contemplating their next move.
3 Reasons to Sell NATR and 1 Stock to Buy Instead
What a time it’s been for Nature's Sunshine. In the past six months alone, the company’s stock price has increased by a massive 63.7%, setting a new 52-week high of $27.62 per share. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
2 Reasons to Like ZTS (and 1 Not So Much)
Over the last six months, Zoetis’s shares have sunk to $129.91, producing a disappointing 16.4% loss - a stark contrast to the S&P 500’s 7.2% gain. This may have investors wondering how to approach the situation.
Central Garden & Pet (CENT): Buy, Sell, or Hold Post Q4 Earnings?
Central Garden & Pet trades at $39.25 per share and has stayed right on track with the overall market, gaining 8.5% over the last six months. At the same time, the S&P 500 has returned 7.2%.
3 Reasons to Sell PAG and 1 Stock to Buy Instead
Over the last six months, Penske Automotive Group’s shares have sunk to $157.70, producing a disappointing 16.3% loss - a stark contrast to the S&P 500’s 7.2% gain. This was partly due to its softer quarterly results and might have investors contemplating their next move.
2 Reasons to Like SLM and 1 to Stay Skeptical
Sallie Mae’s stock price has taken a beating over the past six months, shedding 34% of its value and falling to $20.93 per share. This may have investors wondering how to approach the situation.